Providing Smarter
Solutions for a
Healthier Life
We are committed to building quality and equity in healthcare by leveraging innovative approaches and technologies to improve the well-being of individuals. At our core, we are dedicated to seek opportunities to provide accessible generic drugs, biosimilars, consumer healthcare products and medical devices for all.
Facilities
Duopharma Biotech has 3 R&D and manufacturing facilities across the Klang Valley in Malaysia – in Klang, Bangi and Glenmarie.
Consumer Healthcare
Duopharma’s Consumer Healthcare portfolio include well-recognised brands in health supplements, over-the-counter medications and skincare.
Halal Initiative
Duopharma Biotech embraces the principle of a hollistic approach to halal pharmaceuticals with the “Halal Built-In, Not Tested For” practice. This ensures that our facilities and products are fully halal compliant.
Our Product
Pharmaceuticals
Duopharma Singapore’s Pharmaceuticals portfolio consists of generic drugs that covers an extensive range of therapeutic classes. This includes cardiovascular, respiratory, sensory and nervous system, musculo-skeletal system and anti-infectives.
An overview of our pharmaceutical products can be viewed below.
Read more
Medical
Devices
Duopharma Singapore’s Medical Devices portfolio comprises a curated range of diabetes care products that aim to provide safe and efficient treatment for individuals living with diabetes.
Read more
Innovative
Solutions
Duopharma Singapore’s Innovative Solutions portfolio aims to introduce unique and high quality products to address the unmet medical needs of Singapore’s population.
Read more
Consumer
Healthcare
Duopharma Singapore’s Consumer Healthcare portfolio include well-recognised brands in product segments such as vitamins, analgesics, anti-histamines, skincare and traditional medicines.
Read more
Company Outlook
“With growth prospects picking up pace and markets steadying in 2024, Duopharma Biotech Berhad is continuing to seek opportunities to provide smarter solutions for a healthier life – from supplying the medicines, consumables and devices needed by Malaysia’s public and private healthcare providers, to making investments and forming partnerships for R&D and distribution of medical innovations. As Malaysia’s leading pharmaceutical company, we hope to help elevate Malaysia as a medical R&D hub, generating sustainable socio-economic and health benefits for the people and the nation.”
Leonard Ariff Abdul Shatar
Group Managing Director
Generic Explained
Generic medicines are regulated by relevant regulatory bodies in each country to ensure their quality, safety, and effectiveness. To be approved as a generic medication, it must have the same active ingredients, dosage form, strength, route of administration, and provide similar therapeutic effects as their branded counterparts. As generic medicines cost a fraction of branded ones, they are cost-effective alternatives that make medical treatment more accessible.
Read more about generic medicine programmes in Singapore.